NDAORALSOLUTION
Approved
Oct 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SOLTAMOX (tamoxifen citrate) is an oral solution formulation of tamoxifen, a selective estrogen receptor modulator (SERM) approved for breast cancer and cystic fibrosis. The drug works by competing with estrogen for receptor binding sites, blocking estrogen-driven proliferation in hormone-sensitive breast cancers. Tamoxifen has been a foundational endocrine therapy in oncology for decades.
$469KPart D
LOE ApproachingProduct is approaching loss of exclusivity with minimal current Medicare spending, indicating a niche or declining commercial profile with limited team expansion opportunity.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Started Sep 2010
84 enrolled
Breast Cancer
Career Relevance
SOLTAMOX currently shows zero linked job openings, reflecting its mature, low-volume commercial profile and approaching LOE status. Career opportunity on this product is limited to small specialty teams managing a niche formulation.
Company
Worked on SOLTAMOX at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.